Establishes a pilot program on upper payment limits for prescription drugs

Summary

The bill establishes a pilot that limits how much state‑run health plans and any private plan that opts in can pay for the ten most expensive prescription drugs, using the lowest price among several Canadian provinces or the wholesale acquisition cost as a ceiling. It forces pharmacies, manufacturers and distributors to sell at or below that ceiling, requires annual reports on savings, and imposes penalties for manufacturers who pull drugs or refuse to negotiate. The aim is to lower drug costs for New Yorkers and reduce state health‑care spending.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share